People

Nathalie Van Bruaene is published in PMV’s current public directory as Senior investment manager. This is the specific publicly documented professional or governance affiliation, including any named related unit; no personal cash investment or exact start date is inferred.

A Synergia Medical director and co-founder of TCDCapital, formerlyTheClubDeal. His investment work includes life sciences, medtech, digital health and CNS/epilepsy, following wealth-management experience atUBS. He holds a UCLouvain management qualification. The current company uses the short nameNicolasRoberti; officialregistry andcurrentTCDdirectory additionallypublishNicolasRobertideWinghe. Nicolas Roberti de Winghe is non-executive partner at TCD Capital. Former UBS Belgium project and sales manager, and an early TCD team member advising portfolio companies on governance and growth. He holds a Louvain School of Management business qualification. The current directory identifies the full name Nicolas Roberti de Winghe and a non-executive partnership, rather than an operating investment role.

Senior Executive Assistant at AI Fund.

Finance executive with earlier CFO roles at SpinLaunch, Ring, SpareFoot and Demand Media.

Hilde Famaey is published in PMV’s current public directory as Board Director. This is the specific publicly documented professional or governance affiliation, including any named related unit; no personal cash investment or exact start date is inferred.

Healthcare venture investor and founder of the first Health Innovation fund in2007. Health Innovations still lists him on its public roster; its current investment activity is existing-portfolio follow-ons. Capricorn explicitly names him on its January2025 HealthtechFundII team; that separate role remains preserved. Historical MRIguidance issuer calls him HealthInnovations partner, without implying a personal investment.

Kjell Mortier is published in PMV’s current public directory as Senior Investment Manager. This is the specific publicly documented professional or governance affiliation, including any named related unit; no personal cash investment or exact start date is inferred.

Michael Kaschke is listed as an external senior adviser to DTCP. The directory identifies this adviser’s professional background as Ex-President and CEO of Zeiss Group. This source-published advisory capacity is distinct from DTCP staff employment and does not prove a personal investment or exact appointment date. Detailed additional career history is not published on this page.

Julie Shah is publicly identified by Lila as Chief Robotics Officer. Heads MIT’s aeronautics and astronautics department and its Interactive Robotics Group. Previously worked at Boeing and holds MIT degrees; researches human-robot collaboration.

John Gregoire is publicly identified by Lila as Chief Autonomous Science Officer. Previously a Caltech research professor leading high-throughput materials discovery. Works on autonomous experimentation and active learning; holds Cornell physics and Concordia degrees.

Rafael Gómez-Bombarelli is publicly identified by Lila as CSO, Physical Sciences. Co-founded Lila and is an MIT materials-science professor researching machine learning, molecular modeling and materials discovery. Holds Salamanca chemistry degrees and co-founded Reverie Labs, acquired by Relay Therapeutics.

Andrew Beam is publicly identified by Lila as Chief Technology Officer. Works on machine learning, biological research and causal inference. Co-founded Generate and is a Harvard epidemiology associate professor; holds NC State computer-science degrees.

Jawad Ahsan is publicly identified by Lila as COO & CFO. Previously CFO at Axon and Market Track after thirteen years at GE. Holds an MIT MBA and a Holy Cross economics degree.

Chris Fussell is publicly identified by Lila as President, Operations. Previously president of McChrystal Group following fifteen years as a US Navy SEAL. Holds University of Richmond and Naval Postgraduate School degrees.

Matthew Porteus is published by Arbor Biotechnologies as Board Member. Arbor lists this professional background: Professor of Definitive and Curative Medicine, Stanford University School of Medicine.

Life-sciences inventor and Flagship Pioneering partner who co-founded Sail Biomedicines and serves on its board.

Luca Naef is CO-FOUNDER & CTO at Proxima Bio, formerly VantAI, contributing to its AI-enabled proximity-medicine discovery platform.

Zachary Carpenter is CO-FOUNDER & CEO at Proxima Bio, formerly VantAI, contributing to its AI-enabled proximity-medicine discovery platform.